Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland

被引:17
|
作者
Schmitz, Susanne [1 ,2 ]
McCullagh, Laura [1 ,2 ]
Adams, Roisin [1 ]
Barry, Michael [1 ,2 ]
Walsh, Cathal [1 ,3 ,4 ]
机构
[1] St James Hosp, Natl Ctr Pharmacoecon, Dublin 8, Ireland
[2] St James Hosp, Trinity Coll Dublin, Trinity Ctr Hlth Sci, Dept Pharmacol, Dublin 8, Ireland
[3] Univ Limerick, HRI, Limerick, Ireland
[4] Univ Limerick, MACSI, Limerick, Ireland
关键词
MULTIPLE CRITERIA; EQUITY; NICE;
D O I
10.1007/s40273-016-0406-z
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Decisions on reimbursement of health interventions in many jurisdictions are informed by health technology assessments (HTAs). Historically, the focus of these has often been cost effectiveness or cost utility, while other criteria were considered informally. More recently, there has been an increasing interest in the formal incorporation of additional criteria using multi-criteria decision analysis. Such an approach has not yet formally been part of decision-making policy in Ireland. Objective The objective of this analysis is to demonstrate that cost effectiveness is not the only criterion influencing reimbursement decisions in Ireland. Furthermore, the aim is to reveal criteria that may have informally influenced reimbursement decisions in the past. Methods A list of potential criteria was identified based on the literature, national guidelines and experience of the national HTA agency. Information on each of these criteria was sought for every assessment conducted in Ireland up to July 2015. A logistic regression was fitted to the data to identify influential parameters. Model selection was performed using the Bolasso method. Results Thirteen criteria were considered in the analysis. Two members of the HTA review team assessed the performance of the interventions against these criteria. Model selection suggests that the incremental cost-effectiveness ratio and quality of evidence could be important drivers of reimbursement recommendations in Ireland. Less important drivers suggested include the year of assessment, the level of uncertainty, as well as safety and tolerability. Conclusion The analysis demonstrates that recommendations for or against the reimbursement of technologies in Ireland are not only driven by cost effectiveness. This highlights the need for more formal inclusion of criteria in the process, to improve transparency and ensure consistency.
引用
收藏
页码:925 / 937
页数:13
相关论文
共 50 条
  • [1] Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland
    Susanne Schmitz
    Laura McCullagh
    Roisin Adams
    Michael Barry
    Cathal Walsh
    [J]. PharmacoEconomics, 2016, 34 : 925 - 937
  • [2] IDENTIFICATION OF IMPORTANT CRITERIA FOR DRUG REIMBURSEMENT DECISION-MAKING AND THEIR RELATIVE IMPORTANCE
    Funagoshi, M.
    Murasawa, H.
    Shimozuma, K.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A661 - A661
  • [3] Evaluating multi-criteria decision-making in health technology assessment
    Kelley, Leah T.
    Egan, Rylan
    Stockley, Denise
    Johnson, Ana P.
    [J]. HEALTH POLICY AND TECHNOLOGY, 2018, 7 (03) : 310 - 317
  • [4] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A11 - A11
  • [5] A RETROSPECTIVE ANALYSIS OF DRUG REIMBURSEMENT DECISIONS IN IRELAND: A MULTI CRITERIA DECISION ANALYSIS APPROACH
    Schmitz, S.
    McCullagh, L.
    Adams, R.
    Barry, M.
    Walsh, C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A465 - A465
  • [6] MULTIPLE-CRITERIA DECISION-MAKING - A RETROSPECTIVE ANALYSIS
    HAIMES, YY
    [J]. IEEE TRANSACTIONS ON SYSTEMS MAN AND CYBERNETICS, 1985, 15 (03): : 313 - 315
  • [7] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT AGENCIES (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A377 - A377
  • [8] Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
    Iskrov, Georgi
    Stefanov, Rumen
    [J]. BALKAN MEDICAL JOURNAL, 2016, 33 (01) : 27 - 35
  • [9] Harmonization of evidence requirements for health technology assessment in reimbursement decision making
    Hutton, John
    Trueman, Paul
    Facey, Karen
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 511 - 517
  • [10] Measuring the Importance of Decision-Making Criteria in Biofuel Production Technology Selection
    Kheybari, Siamak
    Mahdi Rezaie, Fariba
    Rezaei, Jafar
    [J]. IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2021, 68 (02) : 483 - 497